Abbvie (ABBV) is in discussions to acquire mental health therapeutics company Gilgamesh Pharmaceuticals, with a potential deal potentially valuing Gilgamesh at roughly $1B, Bloomberg’s Eyk Henning, Madison Muller, and Liana Baker report, citing peopl… [302 chars]
